EUDA Health Holdings Limited (NASDAQ:EUDA) — Market Cap & Net Worth
Market Cap & Net Worth: EUDA Health Holdings Limited (EUDA)
EUDA Health Holdings Limited (NASDAQ:EUDA) has a market capitalization of $13.23 Million ($13.23 Million) as of May 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26178 globally and #5233 in its home market, demonstrating a 33.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EUDA Health Holdings Limited's stock price $15.28 by its total outstanding shares 1890374 (1.89 Million). Analyse EUDA cash flow metrics to see how efficiently the company converts income to cash.
EUDA Health Holdings Limited Market Cap History: 2021 to 2026
EUDA Health Holdings Limited's market capitalization history from 2021 to 2026. Data shows growth from $18.43 Million to $28.88 Million (11.06% CAGR).
Index Memberships
EUDA Health Holdings Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #750 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2467 of 3165 |
Weight: EUDA Health Holdings Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
EUDA Health Holdings Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EUDA Health Holdings Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.13x
EUDA Health Holdings Limited's market cap is 2.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $18.43 Million | $4.56 Million | $864.83K | 4.04x | 21.31x |
| 2022 | $3.12 Million | $3.76 Million | -$24.88 Million | 0.83x | N/A |
| 2023 | $2.70 Million | $3.71 Million | -$10.04 Million | 0.73x | N/A |
| 2024 | $8.56 Million | $4.01 Million | -$15.36 Million | 2.13x | N/A |
Competitor Companies of EUDA by Market Capitalization
Companies near EUDA Health Holdings Limited in the global market cap rankings as of May 3, 2026.
Key companies related to EUDA Health Holdings Limited by market ranking:
- Vingroup JSC (VN:VIC): Ranked #433 globally with a market cap of $60.97 Billion USD ( ₫1604.73 Trillion VND).
- CBRE Group Inc Class A (NYSE:CBRE): Ranked #629 globally with a market cap of $42.20 Billion USD.
- Vonovia SE (XETRA:VNA): Ranked #1124 globally with a market cap of $22.72 Billion USD ( €19.43 Billion EUR).
- VONOVIA SE ADR 1/2/O.N (F:VNAA): Ranked #1166 globally with a market cap of $21.78 Billion USD ( €18.63 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #433 | Vingroup JSC | VN:VIC | $60.97 Billion | ₫214000.00 |
| #629 | CBRE Group Inc Class A | NYSE:CBRE | $42.20 Billion | $141.81 |
| #1124 | Vonovia SE | XETRA:VNA | $22.72 Billion | €22.91 |
| #1166 | VONOVIA SE ADR 1/2/O.N | F:VNAA | $21.78 Billion | €11.50 |
EUDA Health Holdings Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, EUDA Health Holdings Limited's market cap moved from $18.43 Million to $ 28.88 Million, with a yearly change of 11.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $28.88 Million | +561.47% |
| 2025 | $4.37 Million | -49.01% |
| 2024 | $8.56 Million | +216.78% |
| 2023 | $2.70 Million | -13.23% |
| 2022 | $3.12 Million | -83.10% |
| 2021 | $18.43 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of EUDA Health Holdings Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.23 Million USD |
| MoneyControl | $13.23 Million USD |
| MarketWatch | $13.23 Million USD |
| marketcap.company | $13.23 Million USD |
| Reuters | $13.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.